Genetic variations in the drug metabolizing enzyme genes, SLC22A2 and EPHX1, and the DNA repair genes, ERCC1 and ERCC2, have been associated with CIN [4, 15]. The gene discussed is SLC22A2; the disease is cervical squamous intraepithelial neoplasia.